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                                                             ABSTRACT 	  	  	  	  
The bone marrow contains a heterogeneous milieu of cells, including macrophages, 
which are key cellular mediators for resolving infection and inflammation. Macrophages are 
most well known for their ability to phagocytose foreign bodies or apoptotic cells to maintain 
homeostasis; however little is known about their function in the bone microenvironment. In the 
current study we investigated the in vitro interaction of murine macrophages and bone marrow 
stromal cells (BMSCs), with focus on the juxtacrine induction of IL-6 signaling and the resultant 
effect on BMSC migration and growth.  The juxtacrine interaction of primary mouse 
macrophages and BMSCs activated IL-6 signaling in the co-cultures, which subsequently 
enhanced BMSC migration and increased BMSC numbers.  BMSCs and macrophages harvested 
from IL-6 knockout mice revealed that IL-6 signaling was essential for enhancement of BMSC 
migration and increased BMSC numbers via juxtacrine interactions. BMSCs were the main 
contributor of IL-6 signaling, and hence activation of the IL-6/gp130/STAT3 pathway. 
Meanwhile, macrophage derived IL-6 remained important for the overall production of IL-6 
protein in the co-cultures. Taken together, these findings show the function of macrophages as 
co-inducers of migration and growth of BMSCs, which could directly influence bone formation 
and turnover. 
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CHAPTER I 
   Introduction  
 
Mesenchymal stem cells (MSCs) and macrophages are cell populations that play 
very important roles in maintaining homeostasis of the bone marrow environment.  MSCs 
are multi-potent cells that differentiate into osteoblasts and form bone [Pittenger et al., 
1999].  Macrophages contribute to the innate immune response by eliminating bacteria, 
viruses, and clearing apoptotic bodies. Certain distinct macrophage subpopulations located 
in the brain (microglia), eye and testes are believed to play key roles in tissue specific 
remodeling and homeostasis [Murray and Wynn 2011]. In the bone marrow, macrophages 
share a common lineage with osteoclasts which are responsible for bone resorption and 
turnover.  Meanwhile, they phagocytose apoptotic cells such as osteoblasts and BMSCs in 
order to maintain homeostasis of the bone marrow environment [McCauley et al., 2014].  
Recently, a new role for macrophages has emerged and is under investigation. This 
role centers on macrophage function in the maintenance of bone marrow homeostasis 
during bone fracture healing [Wu et al., 2013].  Macrophages are one of the earliest and 
most abundant cells in the bone environment after injury and are instrumental for normal 
bone healing by clearing local apoptotic cells and subsequently signaling to initiate bone 
formation [Chang et al. 2008; Pettit et al. 2008]. Interestingly, when macrophages were 
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depleted from the healing sites, there was significant suppression of bone matrix deposition 
and bone mineralization [Alexander et al., 2011]. Furthermore, osteal macrophages located 
in the lining-tissue of the bone surface support physiologic skeletal remodeling and anabolic 
actions of parathyroid hormone in bone [Cho et al., 2014]. Depletion of myeloid lineage 
cells reduced cortical and trabecular bone mass and attenuated PTH-induced trabecular 
bone anabolism. Taken together, these results indicate that the macrophage function of 
clearing apoptotic cells in the bone marrow may consequently direct bone formation. 
Within bone injury sites, cell-to-cell contact between macrophages and osteoblasts 
or bone marrow stromal cells (BMSCs) widely exists and is an essential step needed for 
macrophage efferocytosis of apoptotic cells. This kind of juxtacrine interaction may cause 
the juxtaposed cells to produce growth factors or pre-inflammatory cytokines, such as TGF-
β [Tang et al., 2009] and IL-6 [Pricolas et al., 2009], and may lead to chemotaxis migration 
effects on BMSCs in the surrounding environment. 
It has been previously reported that the juxtacrine interaction of human myeloma-
derived cells and BMSCs stimulates IL-6 secretion [Uchiyama et al., 1993]. Cytokine array 
data also identified a significantly higher level of IL-6 production from juxtacrine culture of 
macrophages and prostate cancer cells [Soki et al., 2014]. IL-6 is a cytokine highly 
expressed in the bone marrow stroma [Ogasawara et al., 1996] and known for its role in 
bone homeostasis [Manolagas 1995; Manolagas and Jilka, 1995], such as maintaining the 
stemness of the mesenchymal stem cell and accelerating cell migration and proliferation 
[Pricola et al., 2009].  A recent study reported that IL-6 enhanced the polarization of 
alternatively activated macrophages in order to resolve inflammation and improve wound 
healing [Fernando et al., 2014].  Furthermore, IL-6 signaling was found to play a vital role 
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in bone anabolism [Cho et al., 2013]. Thus, in this study, in order to explore the IL-6 
mediated events in bone marrow triggered by the juxtacrine interaction of BMSCs, the 
effect of the juxtacrine interaction of mouse primary macrophages and BMSCs on IL-6 
signaling and its effect on the migration and growth of BMSCs were assessed in vitro. 
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CHAPTER II  
Materials and Methods 
 
Agents 
Cell culture medium and reagents were purchased from Invitrogen. For Western 
blots, the mouse β-Actin monoclonal antibody was from Sigma (St. Louis, MO), and 
mouse STAT3 and phospho-STAT3 monoclonal antibodies were from Cell Signaling 
(Boston, MA). The mouse IL-6 ELISA system, recombinant mouse IL-6, and human 
soluble glycoprotein protein 130 (sgp130) were purchased from R&D Systems 
(Minneapolis, MN). 
 
	  	  	  
Cell Culture 
Bone marrow stromal cells (BMSCs) were flushed from femurs and tibiae of 4-8 week-
old C57BL/6 mice (in-house bred; originally obtained from Jackson Labs, Bar Harbor, 
ME) and IL-6 KO mice (kindly provided by Evan Keller, University of Michigan, Ann 
Arbor, MI) and were incubated at 37°~ in 95% O2/5% CO2 in α-MEM medium  
supplemented with 20% fetal bovine serum, 1% penicillin/streptomycin, 1% glutamine 
(Invitrogen) and 10-8M dexamethasone (Sigma). Bone marrow derived macrophages 
were procured by culturing flushed bone marrow in α-MEM medium containing 10% 
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FBS, penicillin/streptomycin, and treating with M-CSF (30 ng/ml) (eBioscience, San 
Diego, CA) for 7 days.  
 
Cell co-culture and preparation of conditioned medium 	  
To co-culture primary macrophages and BMSCs, 1x 105 bone-marrow derived 
macrophages were seeded first into 6-well plates, cultured 24h, then 1x 105 primary 
mouse BMSCs or apoptotic BMSCs (exposed to UV light treatment for 30 min) were 
placed on the macrophages in α-MEM medium containing 10% FBS. The co-cultures 
were harvested at different time points (2, 4, 6, 24 h). At each time point, macrophages 
cultured alone, apoptotic BMSCs cultured alone, and BMSCs cultured alone were used as 
controls. The supernatants from all cultures were collected and stored at -80°C until used 
as conditioned medium, or for IL-6 ELISA assay. Total RNA of cell cultures was 
harvested at 2 and 4h. Protein lysates of cell cultures were harvested at 6 and 24h. 	  	  
Scratch assay 	  
Primary mouse BMSCs were cultured in 24-well plates coated with collagen type 
I (Costar).  Upon reaching confluence, the center of cell monolayers were scraped with a 
200µl pipette tip. Cells were washed three times with PBS, then cultured with medium 
containing 1% serum and IL-6 protein (10ng/ml), or with different conditioned media for 
8h. To determine whether the effect was gp130/IL6/STAT-3 pathway dependent, the 
cells were pretreated with 1µg/ml sgp130 or vehicle control 1h before IL-6 treatment, or 
conditioned medium treatment.  Photographs were taken on the cell cultures at and after 
cell scratching, and the width of gaps was measured by using the interactive 
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measurement line tool. The fraction of initial defects after BMSC migration were 
calculated and compared among the different groups. Experiments were performed in 
duplicate.  
 
In vitro BMSC migration assay 
Migration assays were performed as described [Tang et al., 2009] with minor 
modifications. Briefly, cell migration was assessed in 24-well plate Transwells (Corning, 
Inc.) with a diameter of 6.5mm and a pore size of 8µm coated with 0.5µg/ml collagen 
type I (Millipore). BMSCs were placed in the upper chambers and conditioned media 
from co-culture, or α-MEM medium containing 10ng/ml IL-6 protein and 1% FBS were 
added to the lower chambers. After 8h, the cells were fixed with 2.5% glutaraldehyde for 
15mins, and the cells remaining on the top of the Transwell membranes were removed 
with cotton swabs. The cells that had migrated through the pores to the lower surface 
were stained with Gill’s hematoxylin (Sigma-Aldrich). Four to five fields at 200x 
magnification were selected at random, photomicrographic images obtained, and the cells 
in each image counted. Experiments were performed in duplicate.  
 
Mouse IL-6 ELISA assay 
IL-6 protein levels in culture supernatants were measured with the Quantikine 
mouse IL-6 ELISA (R&D systems) per manufacturer’s instructions.  Briefly, supernatant 
samples, standards, and controls were added to the anti-mouse IL-6 antibody pre-coated 
microplate and incubated at room temperature for 2 h. Wells were washed extensively 
and then incubated with the IL-6 conjugate for another 2 h. After extensive washing, the 
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substrate solution was added and incubated for 30mins, followed by addition of the stop 
solution, and A450 values were measured using a microplate reader (Biochrom, 
Cambridge, UK). 
 
Cell growth assay 
BMSCs were plated at 1x105 cells/well in a 24 well plate for all groups of 
conditioned medium or α-MEM medium containing 1% FBS supplied with 10ng/ml 
mouse recombinant IL-6. For spg130 inhibition, cells were pretreated with vehicle 
control (BSA) or sgp130 (1µg/ml) for 1 hour before adding IL-6. Growth of cells was 
assessed by hemacytometer counting at 1, 2, and 3d after plating. For counting, each 
condition was plated in triplicate and duplicate counts of trypan blue negative cells per 
well were calculated (mean ± S.E.). 
 
Gene expression by Real-time RT-PCR 
Total RNA was isolated with TRIzol reagent (Invitrogen) from primary BMSCs 
and macrophages either alone or in coculture after 2 and 4h.  Reverse transcription PCR 
was conducted, and the cDNA products were amplified and detected using TaqMan 
Universal PCR master mix (Applied Biosystems, Foster City, CA) and TaqMan probes, 
including mouse IL-6 (Mm03413826_mH), and mouse glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH, Mm00446190) as an endogenous control. Real time PCR was 
analyzed on ABI PRISM 7700 (Applied Biosystems, Foster City, CA). 
 
Western blot 
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After juxtacrine culture of mouse primary macrophages and BMSCs for 6 and 
24h, cell lysates were prepared in lysis buffer containing 1% Nonidet P-40, 5% sodium 
deoxycholate, 1mM phenylmethylsulfonyl fluoride, 100mM sodium orthovanadate, and 
1:100 protease inhibitor mixtures (Sigma). The protein concentration was measured using 
the Bio-Rad Protein detection system according to the manufacturer’s instructions (Bio-
Rad). Fifteen µg protein extracts were subjected to 10% SDS-PAGE and transferred to a 
polyvinylidene difluoride membrane (Bio-Rad) using a wet gel transfer system. The 
membranes were blocked with 5% nonfat milk 1h at 4°C, then probed with the primary 
antibodies overnight at 4°C. The immunocomplexes were visualized with horseradish 
peroxidase-coupled goat anti-rabbit or anti-mouse IgG (Promega) using the SuperSignal 
reagents (Pierce). The quantification of western blot signals was performed with 
Scionimage software (NIH).   
 
Statistical analyses 
Statistical analyses were performed using unpaired t tests. A p value below 0.05 
was considered statistically significant. One asterisk (*) represents a p value below 0.05, 
two (**) represent a p value below 0.01. Data are presented as mean ± S.E. All 
experiments were repeated a minimum of 2 times and representative assays presented. 
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CHAPTER III 
 
                                    Results 
 
 
Juxtacrine interaction of BMSCs and macrophages induced IL-6 activation 
Our laboratory has previously shown by cytokine array that juxtacrine interaction of bone 
marrow derived macrophages and high apoptotic prostate cancer cells significantly increased the 
presence of IL-6 proteins in the media after 24 hours of co-culture [Soki et al., 2014]. We 
speculated that the increased IL-6 contributed to the polarization of macrophages into M2 cells 
that aid in repair and resolution. Uchiyama reported higher IL-6 production when BMSCs were 
co-cultured with PU13 (human myeloid cancer cells) [Uchiyama et al., 1993]. Thus, we 
hypothesized that juxtacrine culture of BMSCs and bone marrow derived macrophages would 
also produce IL-6.  
IL-6 mRNA levels in cells co-cultured for 2 or 4 hours were analyzed. In order to 
determine the effect of phagocytosis of apoptotic BMSCs by the macrophages on IL-6 mRNA 
levels, either the normal BMSCs or the apoptotic BMSCs were co-cultured with macrophages. 
To induce the apoptosis of BMSCs, cells were treated by UV light for 30 minutes, followed by 
incubation for another 2 hours. It was found that more than 90% of the cells were positive by 
trypan blue staining.  Results from UV-treated BMSCs alone was not included in the Q-PCR 
experiment since the majority of cells were killed. The Q-PCR results showed that the juxtacrine 
culture of macrophages and BMSCs expressed the highest levels of IL-6 mRNA, compared to 
either macrophages and BMSCs alone, or the juxtacrine culture of macrophages and apoptotic 
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BMSCs (Fig.1A).  
Over time, IL-6 protein levels in the supernatant from the BMSC and macrophage 
juxtacrine co-cultures were significantly higher at 2, 4, 6, and 24h evidenced by ELISA (Fig 1B). 
To further investigate the IL-6/STAT3 pathway activation in the cultures, the cell protein lysis 
was harvested at 6 hours of co-culture, and STAT3 phosphorylation evaluated by western blot. 
Juxtacrine culture of macrophages and BMSCs exhibited the highest p-STAT3 expression when 
compared to other groups (Fig 1C,D). 
Thus, the juxtacrine interaction of macrophages and live BMSCs significantly induced 
IL-6 signaling, while macrophage coculture with apoptotic BMSCs did not induce IL-6 
production. 
 
Conditioned media from juxtacrine cultures accelerated cell migration and BMSC 
numbers 
The juxtacrine interaction of BMSCs and macrophages occurring in the bone marrow 
may affect the surrounding cells in the bone marrow environment by releasing vital signals. 
Since IL-6 was produced in juxtacrine cultures, and a recent study showed IL-6 promoted wound 
healing by stimulating the cell growth and migration of BMSCs [Pricola et al., 2009], we 
questioned whether the juxtacrine signals of BMSCs and macrophages could indeed effect the 
migration and growth of BMSCs found in the local bone marrow environment. To investigate 
cell migration, we employed a cell scratch assay (Fig 2C,D) and a Transwell assay of BMSCs 
(Fig 2A, B).  BMSCs were cultured for 8 hours in the different groups of conditioned medium.  
In both assays, conditioned medium from co-culture of BMSCs and macrophages significantly 
11	  	  
induced cell migration of BMSCs. Additionally, the stimulation of conditioned media from 
BMSC and macrophage co-cultures, resulted in significantly higher BMSC numbers at 1, 2, 3 
days compared to control conditioned medium (Fig 2E). The dead cell ratio among the whole 
population was also measured by counting the positive cells via trypan blue staining, which 
showed no significant difference among the groups (data not shown). Thus, the conditioned 
medium from juxtacrine culture of BMSCs and macrophages induced cell migration and 
numbers of BMSCs. 
 
Conditioned medium from IL-6 KO mouse cell cultures did not accelerate cell migration 
and BMSC cell numbers 
In order to investigate the role of IL-6 signaling in the enhanced cell migration and 
growth of BMSCs induced by conditioned medium of juxtacrine BMSC and macrophage 
cultures, IL-6 KO and WT mice were utilized to harvest BMSCs and macrophages in order to 
compare the effects of the conditioned medium of juxtacrine cultures with or without IL-6 
protein on BMSCs.  
Conditioned medium was collected from juxtacrine cultures as before from either IL-6 
KO BMSCs and IL-6 KO macrophages or WT BMSCs and WT macrophages. Elevation of IL-6 
protein in the juxtacrine conditioned media from wild-type cells, and absence of IL-6 protein in 
the conditioned media from IL-6 KO cells was confirmed by ELISA assay (Fig 3A). Both groups 
of conditioned medium (from either WT or KO mice) were applied to the Transwell assays (Fig 
3B) and cell scratch assays (Fig 3C) to compare their effects on cell migration of BMSCs. Both 
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assays revealed that only the conditioned media generated from WT cells accelerated the 
migration of BMSCs, while the conditioned media from IL-6 KO cells was unable to elicit the 
same effect.  Additionally, cell numbers from BMSC cultures were counted 1, 2, and 3 days after 
stimulation with the conditioned media from either WT cells or IL-6 KO cells, and the results 
showed only conditioned media from WT cells significantly increased cell numbers (Fig3D). 
 
BMSCs are the main contributing cells of juxtacrine IL-6 production 
A previous report suggested that human BMSCs were the primary cells to produce IL-6 
protein when co-cultured with human myeloid cancer cells [Uchiyama et al., 1993]. However,  
the direct evidence for this speculation was not provided. In order to clarify whether it was 
BMSCs, macrophages, or both, which generate IL-6 in co-culture, co-cultures were established 
with WT-BMSCs and WT-macrophages, WT-BMSCs and IL-6 KO-macrophages, IL-6 KO-
BMSCs and WT-macrophages, IL-6 KO-BMSCs and IL-6 KO-macrophages. The analysis of 
conditioned medium from these four groups and their single culture controls resulted in ~50% 
reduction of IL-6 protein in WT-BMSC + IL-6 KO-macrophage cultures compared with co-
cultures from wild-type cells. IL-6 KO in BMSCs, demonstrated low levels of IL-6 protein in the 
conditioned media, despite the phenotype of macrophages (Fig 4).  
These results provided strong evidence that BMSCs were the major source of IL-6 in the 
juxtacrine cultures. When IL-6 production was ablated in BMSCs from IL-6 KO mice, the 
juxtacrine culture no longer induced IL-6 production. The experimental data from co-culture of 
macrophages with apoptotic BMSCs also supported this result. Once BMSCs were treated with 
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UV light to induce their apoptosis, their co-culture with macrophages no longer produced IL-6 
mRNA or protein (Fig.1A, B).   
 
IL-6 protein accelerated cell migration and number by activation of IL-6/gp130/STAT3 	  
In order to investigate downstream cell signaling , STAT3 phosphorylation was 
evaluated. For those studies, the soluble gp130 protein (sgp130), an inhibitor of the 
gp130/STAT3 pathway, was used to treat cells 1 hour before IL-6 stimulation. Western blot 
analyses demonstrated that after 30 minutes of treatment with IL-6, there was a significant 
increase in STAT3-phosphorylation which was blocked by the sgp 130 inhibitor (Fig 5A.B).  
When BMSCs were treated with IL-6 (10ng/ml) in the Transwell and cell scratch assays 
for 8h, or cultured in the dishes for 1, 2, and 3d, IL-6 protein significantly increased BMSC 
migration (Fig 5C-E), and increased cell numbers (Fig 5F). Pretreatment of the cultures with 
sgp130 (1µg/ml) 1 hour prior to IL-6 treatment attenuated the effect of IL-6 treatment. 
 These data highlight that IL-6 protein directly accelerates cell migration and cell 
numbers of BMSC by its activation of IL-6/gp130/STAT3 signaling pathway. 
 
Juxtacrine cultures accelerated BMSC migration and number via IL-6/gp130/STAT3 	  
The data presented above showed that the juxtacrine interaction of BMSCs and 
macrophages induced IL-6 which led to cell migration and increased BMSC numbers. To 
investigate the related underlying mechanism of this juxtacrine interaction, 
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related to IL-6 in the co-cultures, such as STAT-3, SOCS-3, ERK and NF-κB were investigated 
by looking at their activations triggered by juxtacrine interactions.  The only pathway found 
activated via the juxtacrine interaction was STAT3 (p-STAT3 data presented in Fig 1, SOCS-3, 
ERK, and NF-κB not shown).  
To further investigate the IL-6/STAT-3 pathway activation, BMSCs were directly treated 
with the conditioned medium from WT and IL-6 KO co-cultures to compare phosphorylation of 
STAT3 by western blot. The results showed that only the conditioned media from WT cell 
juxtacrine co-cultures could stimulate the phosphorylation of STAT3, while the conditioned 
media from IL-6 KO cell co-culture was unable to elicit the same effect (Fig 6A,B). This 
indicated that lack of STAT3 activation in IL-6 KO juxtacrine conditioned media may contribute 
to its lack of ability to induce cell migration and increase cell numbers of BMSCs. To validate 
this finding, sgp130 was applied together with conditioned media from WT cell co-cultures, to 
evaluate its effect on cell migration and BMSC numbers. It clearly showed that, sgp130 
attenuated the cell migration (Fig 6C-E) and cell proliferation (Fig 6F) accelerated by the 
conditioned media from WT cell co-cultures (Fig 6C-E) and increased BMSC numbers (Fig 6F).   
Thus, the conditioned media from juxtacrine cultures accelerated cell migration and 
increased cell numbers by its activation of the IL-6/gp130/STAT3 pathway. 
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CHAPTER IV 	  
Discussion 	  	  
Little information is known as to how macrophages function in the bone 
microenvironment beyond their role as scavengers to cleanse the bone marrow of apoptotic cells 
[Murray and Wynn, 2011]. Recent studies from our laboratory and others have found that the 
macrophages located within bone marrow, exist as tissue resident macrophages involved in bone 
formation and mineralization in vitro and in vivo [Chang et al., 2008; Alexander et al., 2011; Cho 
et al., 2014]. This phenomenon begs the question: What is the role of macrophages in the bone 
marrow in accelerating or maintaining bone formation? Since macrophages themselves do not 
produce bone matrix proteins, they must affect the function of either osteoblasts, which produce 
bone matrix, or their mesenchymal stem cell (MSC) precursors found in the bone 
microenvironment. To answer the question, we should not only look at the function of 
macrophages alone, but rather put them into the whole skeletal system and within the scope of 
osteoimmunology.  Recently, studies have started to explore the interaction of immune cells with 
skeletal cells and to identify shared pathways and signaling molecules, in order to find 
osteoimmunological interactions in health and disease [McHugh 2008]. Thus, in the present 
study, we investigated the function of macrophages in bone development by investigating their 
juxtacrine interaction with BMSCs. Central to our findings was the role of IL-6. 
IL-6 is a multifunctional cytokine that regulates various aspects of immune responses, 
acute-phase reactions and haematopoiesis [Kopf et al.,1994]. In the skeletal system, IL-6 is 
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important in PTH induced bone resorption [Grey et al., 1999], is involved in osteoclast 
differentiation [Palmqvist et al., 2002], and PTH induced support of hematopoietic progenitor 
cell expansion in bone marrow [Pirih et al., 2010].  IL-6 also stimulates osteoblastic proliferation 
through the gp130/STAT3 pathway [Sims et al., 2004], maintains mesenchymal stem cell (MSC) 
stemness, and accelerates MSC migration and proliferation during wound healing [Pricola et al., 
2009]. All of these findings indicate that IL-6 plays multiple functions in regulating bone 
metabolism and growth. Recently, other experiments in our lab showed a significant increase in 
the level of IL-6 protein found in the conditioned medium collected from co-culture of bone 
marrow macrophages and apoptotic prostate cancer cells, which may be linked to the 
polarization of macrophages induced by efferocytosis [Soki et al., 2014]. Thus, we hypothesized 
that under physiological conditions, the juxtacrine interaction of macrophages and apoptotic 
BMSCs or osteoblasts occurring in bone turnover sites could induce IL-6 production, which 
would affect migration and growth of BMSCs from the local surrounding environment towards 
the turnover sites thus replacing the apoptotic cells phagocytosed by the macrophages, and hence 
contribute to bone formation and maintenance of bone homeostasis.  
Experiments were performed to investigate the effect of juxtacrine interaction of 
macrophages and BMSCs on IL-6 expression by co-culturing primary bone marrow derived 
macrophages and highly apoptotic BMSCs induced by UV light treatment. Concurrently, we also 
set up juxtacrine cultures of macrophages and normal BMSCs as a control group to explore 
whether efferocytosis specifically alters IL-6 expression at the mRNA or protein level. 
Surprisingly, only juxtacrine cultures of live BMSCs and macrophages significantly supported 
IL-6 expression, while there was no increase of IL-6 expression in the juxtacrine cultures of 
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apoptotic BMSCs and macrophages. When the conditioned media from co-cultures were used to 
investigate the migration and cell numbers of BMSCs, only the conditioned media from co-
cultures of live BMSCs and macrophages showed significant changes, instead of the conditioned 
media from the co-culture of apoptotic BMSCs and macrophages. There are several possibilities 
to explain this: 1) BMSCs are the primary cells to produce IL-6 triggered by the juxtacrine 
interaction. This hypothesis is supported by Uchiyama’s study on juxtacrine culture of human 
myeloma-derived cell lines and BMSCs. In their study, significant IL-6 secretion was found in 
co-cultures of a myeloma-derived cell line and BMSCs, however if the BMSCs were fixed with 
paraformaldehyde before co-culture, the IL-6 secretion was completely abrogated [Uchiyama et 
al., 1993].BMSCs and macrophages produce IL-6 after the trigger of juxtacrine interactions in a 
temporal manner. Analysis of the IL-6 protein in the conditioned media from co-cultures of 
combinations of WT- and IL-6 KO-BMSCs with WT- and IL-6 KO-macrophages, demonstrated 
that IL-6 expression by BMSCs is essential for the induction of IL-6 in macrophages during the 
juxtacrine interactions. When BMSCs from IL-6 ablated mice were used, the juxtacrine cultures 
could no longer trigger the expression of IL-6 protein. However, when macrophages from IL-6 
ablated mice were used, there was ~50% reduction of IL-6 induction in the juxtacrine cultures. 
Thus, there may be a sequential effect of synthesis of IL-6 by the juxtacrine cultures in which 
BMSCs may be induced to produce IL-6 first. Therefore, when IL-6 can be normally synthesized 
in WT BMSCs and secreted outside the cells in a paracrine manner, it may stimulate 
macrophages to produce and secrete more IL-6 protein in both a paracrine manner and an 
autocrine feedback loop, which would explain the much higher total production of IL-6 seen in 
the whole WT co-cultures. When IL-6 was unable to be produced from the macrophages in the 
juxtacrine cultures, the whole amount of IL-6 secretion by the juxtacrine cultures was 
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compromised. This experiment provides evidence to support that both BMSCs and macrophages 
are contributors for the production of IL-6 proteins in a temporal manner. 
During the juxtacrine culture of macrophages and BMSCs, many cytokines and growth 
factors are secreted. In order to identify whether IL-6 was the specific inducer of migration and 
growth of BMSCs, we utilized IL-6 knockout mice to generate BMSCs and macrophages. By 
comparing the migration and cell growth of BMSCs stimulated with conditioned media from co-
cultures of WT cells and IL-6 KO cells, it was found that only conditioned media containing IL-
6 stimulated the migration and increased the cell numbers of BMSCs, while conditioned media 
lacking IL-6 could not. However, the conditioned media from co-culture of macrophages and 
apoptotic BMSCs did show a trend of increasing migration of BMSCs, although its IL-6 protein 
levels were as low as those from BMSC cultures and macrophage cultures alone (data not 
shown). Therefore, we cannot completely exclude other growth factors and cytokines that may 
also play a role. Thus, further experiments, such as gene comparisons, would definitely provide a 
more comprehensive profile for evaluation.  
In the present study, STAT3 was found to be activated in BMSCs by stimulation of either 
exogenous IL-6 protein, or the conditioned media from co-cultured macrophages and BMSCs. 
STAT3 is the downstream regulator of gp130/IL-6 pathway, and its activation can be blocked by 
soluble gp130 [Cho et al. , 2013; Garbers et al., 2011, ].  To investigate whether conditioned 
media or IL-6 protein enhances migration and growth of BMSCs via their activation of the 
gp130/STAT3 pathway, soluble gp-130 (sgp130) was utilized in the cell migration and cell 
numbers assays. The data showed that once gp130/STAT3 activation in BMSCs was blocked by 
sgp130, the increase in migration and cell numbers of BMSCs by IL-6 protein or conditioned 
19	  	  
media treatment was abolished. Co-cultures of BMSCs and macrophages also exhibited the 
highest level of STAT3 phosphorylation, which is consistent with the change in IL-6 protein 
levels. This means that the IL-6/STAT3 pathway in the co-cultures was activated by the IL-6 
produced and secreted into the conditioned media, suggesting a positive autocrine feedback loop 
in such a co-culture environment which may function to augment IL-6 signals to neighboring 
BMSCs.   
In summary, we found the juxtacrine interactions of BMSCs and macrophages alters the 
biological function of BMSCs through the IL6/gp130/STAT3 pathway. Our laboratory 
previously reported that sIL-6R up-regulated myeloid cell expansion and production of 
transforming growth factor-β (TGF-β) in the bone microenvironment [Cho et al., 2013].  A next 
step would be to examine the effect of this juxtacrine interaction on sIL-6R expression and its 
effects on myeloid cell expansion.  Indeed, while our current study focused on the function of 
juxtacrine interaction of macrophages and BMSCs from mice under physiologic conditions, it 
would be interesting to investigate the juxtacrine relationship under certain disease models such 
as bone fracture healing or in the context of age related osteoporosis. 
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Conclusion 
 	  	  
Juxtacrine interactions of BMSCs and macrophages activated the secretion of IL-6 into 
co-culture supernatants that accelerated cell migration and increased BMSC numbers via 
activation of the IL-6/gp130/STAT3 pathway in BMSCs. While BMSCs in the juxtacrine 
cultures were the primary contributor for the secretion of IL-6, macrophages did contribute to the 
overall production of IL-6 (Fig 7). These findings are important for understanding the function of 
macrophages in bone formation by effecting the migration and growth of BMSCs in the bone 
microenvironment.  
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Figure 1.  	  
 
Figure 1.  Juxtacrine interaction of BMSCs and macrophages (MФ) induced IL-6 
activation. (A) Real-time PCR revealed significantly higher levels of IL-6 mRNA at 2 and 4h in 
co-cultures of mouse primary macrophages and BMSCs compared to co-cultures of macrophages 
and apoptotic BMSCs (UV treated), or macrophage and BMSC cultures alone. Data are mean ± 
S.E.M. (n=2/group); **p<0.01. (B) ELISA assay showed significantly higher levels of IL-6 
protein in the supernatant from co-culture of mouse primary macrophages and BMSCs at 2h, 4h, 
6h, and 24h compared to coculture of macrophages and apoptotic BMSCs, or macrophage and 
BMSC cultures alone. Data are mean ± S.E. (n=2/group); *p<0.05** p<0.01.  (C) Western blot 
analysis showed endogenous STAT3 phosphorylation was increased in co-cultures of primary 
macrophage and BMSCs after 6h when compared with either co-culture of macrophages and 
apoptotic BMSCs, or BMSCs, apoptotic BMSCs and macrophages alone. (D) Quantification for 
phosphorylated STAT3 protein expression in 1C was determined by relative expression of 
phosphorylated STAT3 to the control β-actin. Data are mean ± S.E.M. of two independent 
experiments and normalized to STAT3 and β-actin control (n=2/group); **p<0.01.  	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Figure 2.  
 
Figure 2. Conditioned media from juxtacrine culture accelerated cell migration and 
increased cell number of BMSCs. (A) Transwell migration assays of mouse BMSCs cultured 
for 8h in conditioned media from co-culture of macrophages and BMSCs, macrophage culture 
alone or BMSC culture alone. The migrated cells were counted after fixation and hematoxylin 
staining. Five fields of view were randomly picked up for each sample, and number of migrated 
cells per field of view was counted. Quantitative results showed conditioned medium from co-
culture of BMSCs and macrophages enhanced the migration of BMSCs. All experiments were 
performed in duplicate. Data are mean ± S.E.M. (n=2/group); *p<0.05. (B) Image of BMSC after 
fixation and hematoxylin staining in the Transwell assays. Images were taken at 200x 
magnification. (C) Cell scratch assay for migration of mouse BMSCs cultured for 8h in 
	  
C 
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conditioned media from co-culture of macrophages and BMSCs, macrophages cultured alone or 
BMSCs cultured alone. Cell scratches were imaged at the time of scratching (start point) and 8h 
after culture with conditioned medium. Images were taken at 100x magnification. (D) The 
remaining distance of scratch in each group was measured by its fraction of initial at the starting 
point. The remaining distance of scratch in BMSC cultures with conditioned media from co-
culture of BMSCs and macrophages was significantly smaller than other two groups. All 
experiments were performed in duplicate. And every group in each experiment consist triplicate 
samples. Data are mean ± S.E.M. (n=3/group); ** p<0.01. (E) Conditioned medium from co-
culture of BMSCs and macrophages increased mouse BMSCs after 1, 2, 3d of culture when 
compared to culture in conditioned medium from BMSCs or macrophages alone. Data are mean 
± S.E.M. (n=3/group); **p<0.01. 
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Figure 3.  
 
Figure 3. Conditioned medium from juxtacrine culture of IL-6 KO mice did not accelerate 
cell migration and cell numbers of BMSCs. (A) ELISA assay showed IL-6 protein 
significantly increased after 24h in the supernatant from co-culture of mouse macrophages and 
BMSCs from wild-type (WT) mice, while no IL-6 protein was secreted by the co-cultures from 
BMSCs and macrophages generated from IL-6 knockout (IL-6 KO) mice. Data are mean ± 
S.E.M. (n=2/group); **p<0.01; *p<0.05. (B) Transwell assays compared the migration of mouse 
BMSCs cultured for 8 h in conditioned media from wild-type cells and in conditioned medium 
from IL-6 KO cells. Migrated cells were counted after fixation and hematoxylin staining. Five 
fields of view were randomly picked for each sample, and the number of migrated cells per field 
of view was counted.  Only conditioned medium of co-cultures from WT cells increased 
migration of BMSCs. All experiments were performed in duplicate. Data are mean ± S.E.M. 
(n=2/group); *p<0.05. (C) Cell scratch assays compared the migration of mouse BMSCs 
cultured for 8h in conditioned media from WT cells or from IL-6 KO cells. Only conditioned 
medium of co-cultures from WT cells increased migration of BMSCs. All experiments were 
performed in duplicate. Data are mean ± S.E.M. (n=3/group); *p<0.05. (D) Only conditioned 
medium of co-culture from WT cells increased mouse BMSC numbers after 1, 2, 3d of culture.  
IL-6 KO groups did not affect cell number. Data were mean ± S.E. (n=3/group); * p<0.05. 
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Figure 4.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4. BMSCs were the main contributing cells for IL-6 protein production from 
juxtacrine interaction (A) ELISA assay showed that after 24h, IL-6 protein was significantly 
increased in the supernatant from co-culture of WT BMSCs and WT macrophages, and co-
culture of WT BMSCs and IL-6 KO macrophages. No elevation of IL-6 protein concentration 
was found in the co-cultures of IL-6 KO BMSCs and either WT macrophages or IL-6 KO 
macrophages. Data are mean ± S.E.M. (n=2/group); **p<0.01. 
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Figure 5. 
            
 
Figure 5. IL-6 protein accelerated cell migration and increased BMSC numbers through 
activation of the IL-6/gp130/STAT3 pathway. (A) BMSCs were treated with recombinant 
mouse IL-6 protein (10ng/ml) for 30 min with or without a 1h pretreatment of sgp130 (1µg/ml). 
Western blot analysis of BMSC protein samples compared phosphorylation of STAT3 
(pSTAT3). IL-6 protein stimulated the phosphorylation of STAT3 in BMSCs, which was 
blocked by spg130 pretreatment. (B) Quantification of p-STAT3 protein expression was 
determined by relative expression of p-STAT3 versus β-actin control. This experiment was 
performed in duplicate. Data are mean ± S.E.M.; **p<0.01; *p<0.05. (C) Transwell assays 
compared the migration of BMSCs cultured for 8h after treatment with IL-6 protein (10ng/ml) 
	  
	  
	  
E	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with or without 1h pretreatment of spg130 (1ug/ml). IL-6 protein treatment increased migration 
of BMSCs, while this effect was abolished by sgp130 pretreatment. The migrated cells were 
counted after fixation and hematoxylin staining. Images were taken at X200 magnification. Five 
fields of view were randomly picked for each sample, and number of migrated cells per field of 
view was counted. All experiments were done in duplicate. Data were mean ± S.E. 
(n=2/group);*p<0.05. (D) Image of BMSC after fixation and hematoxylin staining in the 
Transwell assays. Images were taken at 200x magnification. (E) Cell scratch assays compared 
the remaining scratch distance of BMSC cultures after 8 h of IL-6 protein (10ng/ml) treatment 
with or without pretreatment of spg130 (1µg/ml). IL-6 protein treatment significantly reduced 
the remaining distance of cell scratch, which was abolished by sgp130 pretreatment. All 
experiments were performed in duplicate. Data are mean ± S.E.M. (n=3/group); *p<0.05. (F) IL-
6 protein treatment (10ng/ml) increased BMSC numbers after 1, 2 and 3d of culture, an effect 
which was abolished by spg130 pretreatment (1µg/ml for 1 h). Data are mean ± S.E.M. 
(n=3/group); *p<0.05; **p<0.01. 
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Figure 6. 
 
Figure 6. Juxtacrine interaction of BMSCs and macrophages accelerated BMSC migration 
and increased BMSC numbers through activation of the IL-6/gp130/STAT3 pathway. (A, 
B) Conditioned medium harvested from either WT or IL-6 KO cell cultures were used to treat 
BMSCs for 30min. Western blot analysis of BMSC proteins compared p-STAT3 levels. Only 
	  
	  
	  
E	   F	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conditioned medium from co-culture of WT macrophages and BMSCs stimulated the 
phosphorylation of STAT3 in BMSCs. IL6 KO conditioned medium could not. Quantification of 
p-STAT3 protein expression was determined by relative expression of p-STAT3 to the control β-
actin. Data are mean ± S.E.M. of two independent experiments and normalized to STAT3 and β-
actin control (n=2/group); *p<0.05. (C, D) Transwell assays compared the migration of mouse 
BMSCs cultured for 8h under the stimulation of conditioned medium from co-culture of WT 
BMSCs and macrophages with or without pretreatment of spg130 (1µg/ml). Pretreatment with 
sgp130 blocked the ability of the conditioned medium to stimulate BMSC migration. The 
migrated cells were counted after fixation and hematoxylin staining. Images were taken at 200x 
magnification. Five fields of view were randomly picked for each sample, and numbers of 
migrated cells per field of view were counted. All experiments were performed in duplicate. Data 
were mean ± S.E.M. (n=2/group); *p<0.05. (E) Cell scratch assays compared the remaining 
scratch distance of BMSC cultures after 8h of conditioned medium from co-culture of WT 
BMSCs and macrophages with or without spg130 pretreatment (1µg/ml). Pretreatment with 
sgp130 blocked the stimulation of conditioned medium on the migration of BMSCs. All 
experiments were performed in duplicate. Data are mean ± S.E.M. (n=3/group); *p<0.05. (F) 
Pretreatment with spg130 (1µg/ml for 1h) abolished the stimulation of conditioned medium on 
BMSC numbers after 1, 2, 3d of culture. Data are mean ± S.E.M. (n=3/group); *p<0.05; 
**p<0.01.  
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Figure 7. 
 
	  	  
Figure 7. The overview of the mechanism of juxtacrine interactions of BMSCs and 
macrophages on BMSC migration and cell numbers.  In the bone marrow environment, 
macrophages differentiate into osteoclasts and BMSCs differentiate into osteoblasts. The 
juxtacrine interaction of BMSCs and macrophages in the local bone marrow environment 
induced IL-6 production by BMSCs thus accelerating BMSC migration and increasing cell 
numbers. The juxtacrine interaction of BMSCs and macrophages accelerated BMSC migration 
and increased BMSC numbers through activation of the IL-6/gp130/STAT3 pathway.	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